#20 Pt2: How the Pill Disrupts the Microbiome Long-Term

Send us Fan MailIn Part 2, Ronny Szelinsky explains the mechanism behind oestrogen-driven microbiome collapse at menopause — and what can be done about it. He introduces the estrobolome, details the research behind Get Happy's Happy Fem probiotic formula, and explains why oral probiotics colonise the gynecological tract as effectively as vaginal delivery. This is the translational bridge between the science of Part 1 and the practical interventions of Part 3.Key TopicsHow oestrogen controls the thickness of the vaginal and endometrial tissue, and what happens when it dropsWhy UTIs become suddenly frequent after menopause — the biological mechanismVaginal dryness and pain during sex: the mucosal layer explainedThe estrobolome: the bacterial community around the ovaries and its proposed role in oestrogen productionThe contraceptive pill and its long-term impact on microbiome colonisation after stoppingHappy Fem: how the product was developed, the research methodology, and the fertility clinic partnershipsWhy oral probiotics achieve equivalent vaginal colonisation to vaginal administration — three pathwaysLactobacillus CA-15: what the published research showsWho should take vaginal probiotics and under what circumstancesWhen to pause: during pregnancy, and whyDosing: six-month courses for specific goals; ongoing daily use for post-menopausal womenTimestamps[Part 2 start] — Hormone-microbiome axis, oestrogen and tissue thickness[~05:00 into part] — Why UTIs spike at menopause[~10:00] — The estrobolome: ovarian bacteria and oestrogen production[~17:00] — Happy Fem: product development and research methodology[~22:00] — Oral vs vaginal administration — clinical study results[~27:00] — Lactobacillus CA-15: what it does[~30:00] — Who should take it; when to pause; dosing logicReferences and ResourcesHappy Fem product: www.get-happy.comLactobacillus CA-15Insta/TikTok: @BiohackingEveWebsite: www.BiohackingEve.com